Compare Align Technology, Inc. (ALGN) vs Oracle Corporation (ORCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Oracle Corporation — how do they compare? Align Technology, Inc. trades at $179.9 (market cap $12.86B), while Oracle Corporation trades at $140.06 (market cap $405.11B). The key difference: Oracle Corporation is far larger — about 31.5× Align Technology, Inc.'s market cap, and Oracle Corporation pays a 1.42% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | ORCL | |
|---|---|---|
Market Cap | $12.86B | $405.11B |
Sector | Health | Technology |
52-Week High | $207.19 | $328.33 |
52-Week Low | $124.88 | $136.39 |
Enterprise Value | $11.92B | $534.36B |
Dividend Yield | — | 1.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Oracle Corporation (ORCL) trades at $140.68, down 2.49% today, amid mixed technical signals with a bearish overall trend. Fundamentally, the company shows strong profitability with 25.37% net income margin and consistent earnings beats in recent quarters. Revenue growth continues with $57.4B in FY2025, while analyst consensus remains bullish with a $259 price target. Recent news highlights Oracle's positioning in AI infrastructure and partnership developments with OpenAI.
Oracle presents a compelling investment case with strong fundamentals and AI growth potential, though technical weakness and high valuation metrics warrant caution. The stock offers upside to analyst targets but faces execution risks in competitive cloud markets and substantial debt levels that could pressure returns if interest rates remain elevated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Oracle Corporation
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Read more on ORCL →
